Squarepoint’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,800
Closed -$463K 4222
2023
Q2
$463K Buy
+8,800
New +$536K ﹤0.01% 2668

Other funds holding STAA

Squarepoint's STAA Position: Q2 2026 in Review

Squarepoint reduced its STAAR Surgical (STAA) stake by 46% in Q2 2026, selling an estimated $4.4M and leaving 188,292 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #1546.

Squarepoint first reported a position in STAA in Q4 2017 and has held it in 21 quarters since. The position peaked at $6.48M in Q1 2026. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Squarepoint held 188,292 shares of STAAR Surgical worth $5.4M as of Q2 2026.
  • Squarepoint sold 158,429 STAAR Surgical shares in Q2 2026, an estimated $4.4M.
  • STAAR Surgical made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1546 holding.
  • Squarepoint first reported a position in STAAR Surgical in Q4 2017 and has held it in 21 quarters since.
  • Squarepoint's STAAR Surgical position peaked at $6.48M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.